No Evidence That Analgesic Use after COVID-19 Vaccination Negatively Impacts Antibody Responses
Bonnie J. Lafleur, Lisa White, Michael D. Dake, Janko Z. Nikolich, Ryan Sprissler, Deepta Bhattacharya · 2023
Read No Evidence That Analgesic Use after COVID-19 Vaccination Negatively Impacts Antibody Responses by Bonnie J. Lafleur, Lisa White, Michael D. Dake, Janko Z. Nikolich, Ryan Sprissler, Deepta Bhattacharya (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10759157.txt.
Description
Bonnie Lafleur and co-authors ask whether painkillers taken after COVID-19 shots weaken the antibody response. Their 2023 study surveys more than two thousand vaccine recipients about drug use after each shot. Low booster uptake had raised worry that side effects deter people.
People who used common pain drugs showed slightly higher antibody levels than those who did not. The pattern held for both major mRNA vaccines and across age groups. Drug users also reported more fatigue, aches, and headaches. Among people with such symptoms, antibody levels did not differ by drug use. The authors read symptoms, not the drugs, as the link to higher levels. They find no sign that pain relief harms response.
Catalog record
| CREATOR | Bonnie J. Lafleur, Lisa White, Michael D. Dake, Janko Z. Nikolich, Ryan Sprissler, Deepta Bhattacharya |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 18 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |